Human Aquaporin 4281-300 is the immunodominant linear determinant in the context of HLA-DRB1*03:01: relevance for diagnosing and monitoring patients with Neuromyelitis Optica.

Arellano, B; Hussain, R; Zacharias, T; Yoon, J; David, C; Zein, S; Steinman, L; Forsthuber, T; Greenberg, BM; Lambracht-Washington, D; Ritchie, AM; Bennett, JL; Stüve, O

doi:10.1001/archneurol.2012.1300

journal article

Title:: Human Aquaporin 4281-300 is the immunodominant linear determinant in the context of HLA-DRB1*03:01: relevance for diagnosing and monitoring patients with Neuromyelitis Optica.
Document type:: Journal Article; Research Support, Non-U.S. Gov't; Article
Author(s):: Arellano, B; Hussain, R; Zacharias, T; Yoon, J; David, C; Zein, S; Steinman, L; Forsthuber, T; Greenberg, BM; Lambracht-Washington, D; Ritchie, AM; Bennett, JL; Stüve, O
Abstract:: OBJECTIVE To identify linear determinants of human aquaporin 4 (hAQP4) in the context of HLA-DRB1*03:01. DESIGN In this controlled study with humanized experimental animals, HLA-DRB1*03:01 transgenic mice were immunized with whole-protein hAQP4 emulsified in complete Freund adjuvant. To test T-cell responses, lymph node cells and splenocytes were cultured in vitro with synthetic peptides 20 amino acids long that overlap by 10 amino acids across the entirety of hAQP4. The frequency of interferon ?, interleukin (IL) 17, granulocyte-macrophage colony-stimulating factor, and IL-5-secreting CD4+ T cells was determined by the enzyme-linked immunosorbent sport assay. Quantitative immunofluorescence microscopy was performed to determine whether hAQP4281-300 inhibits the binding of anti-hAQP4 recombinant antibody to surface full-length hAQP4. SETTING Academic neuroimmunology laboratories. SUBJECTS Humanized HLA-DRB1*03:01+/+ H-2b-/- transgenic mice on a B10 background. RESULTS Peptide hAQP4281-300 generated a significantly (P < .01) greater TH1 and TH17 immune response than any of the other linear peptides screened. This 20mer peptide contains 2 dominant immunogenic 15mer peptides. hAQP4284-298 induced predominantly an IL-17 and granulocyte-macrophage colony-stimulating factor TH cell phenotype, whereas hAQP4285-299 resulted in a higher frequency of TH1 cells. hAQP4281-300 did not interfere with recombinant AQP4 autoantibody binding. CONCLUSIONS hAQP4281-330 is the dominant linear immunogenic determinant of hAQP4 in the context of HLA-DRB1*03:01. Within hAQP4281-330 are 2 dominant immunogenic determinants that induce differential TH phenotypes. hAQP4 determinants identified in this study can serve as diagnostic biomarkers in patients with neuromyelitis optica and may facilitate the monitoring of treatment responses to pharmacotherapies.
Journal title abbreviation:: Arch Neurol
Year:: 2012
Journal volume:: 69
Journal issue:: 9
Pages contribution:: 1125-31
Language:: eng
Fulltext / DOI:: doi:10.1001/archneurol.2012.1300
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/22751865
Print-ISSN:: 0003-9942
TUM Institution:: Neurologische Klinik und Poliklinik
BibTeX

Occurrences:

mediaTUM Gesamtbestand Einrichtungen Schools TUM School of Medicine and Health Departments Clinical Medicine Klinik und Poliklinik für Neurologie (Prof. Hemmer)2012